School of Medicine

Deborah C. Rubin, M.D., has been named director of the Master of Arts and Doctor of Medicine Program (M.A./M.D.) at the School of Medicine.

Taking into account that each of us has unique physical characteristics partly determined by variations in our genes, pharmacogenetics researchers at the School of Medicine are finding ways to personalize cancer treatments.

Photo by Robert BostonM.D.-Ph.D. student Danielle Scheidenhelm works with STARS program participant Diane Ma.54 high-schoolers participated in the program, which pairs students and teachers with research mentors from area universities.

Commonly refer to them as natural killer cells, they rapidly attack invaders and are continually generated in the bone marrow.

Cardiac researchers have found treatment with anti-inflammatory drugs after heart surgery may lessen or prevent atrial fibrillation.

University researchers used questionnaires, physical examinations and laboratory tests to assess symptoms and disability levels.

The National Cancer Institute has awarded the center a five-year, $1.25 million grant to support its Program for the Elimination of Cancer Disparities.

However, Medicaid, Medicare and many private insurers specify CT (computed tomography) for diagnosing and monitoring this cancer.

Applications are being accepted for the University’s American Cancer Society Institutional Research Grant.

Photo by Robert BostonBio Med RAP is a summertime program that prepares students for Ph.D. and M.D. programs in biomedical sciences.